### Randomly produced the initial vaccine ###
Polytope vaccine with 15 neo-epitopes: VLNDILSRLaKCYGVSPTKKIADYNYKLwdgSIIAYTMSLpecRLQSLQTYVLTDEMIAQYggYLQPRTFLLgknhFIAGLIAIVgiwsiQYIKWPWYInNYNYLYRLF
Table1. Presented peptides in the selected-epitopes
Alleles  |  Epi  |  %Rank
HLA-A*02:01 | VLNDILSRL | 0.028
HLA-A*02:01 | KIADYNYKL | 0.067
HLA-A*02:01 | SIIAYTMSL | 0.300
HLA-A*02:01 | RLQSLQTYV | 0.062
HLA-A*02:01 | YLQPRTFLL | 0.013
HLA-A*02:01 | FIAGLIAIV | 0.241
HLA-A*01:01 | LTDEMIAQY | 0.001
HLA-A*03:01 | KCYGVSPTK | 0.253
HLA-A*24:02 | QYIKWPWYI | 0.019
HLA-A*24:02 | NYNYLYRLF | 0.054
HLA-B*08:01 | SIIAYTMSL | 0.448
HLA-B*08:01 | YLQPRTFLL | 0.019
HLA-B*35:01 | LTDEMIAQY | 0.342

Table2. Presentation of neo-epitopes
Alleles  |    |  Epi  |  %Rank
HLA-A*02:01 | KLWDGSIIA | 0.048
HLA-A*02:01 | FLLGKNHFI | 0.019
HLA-A*01:01 | YINNYNYLY | 0.118
HLA-A*03:01 | GIWSIQYIK | 0.294
HLA-A*24:02 | GYLQPRTFL | 0.287
HLA-A*24:02 | TFLLGKNHF | 0.123
HLA-A*24:02 | IWSIQYIKW | 0.184
HLA-A*24:02 | WYINNYNYL | 0.203
HLA-A*11:01 | GIWSIQYIK | 0.186
HLA-B*07:02 | LPECRLQSL | 0.188
HLA-B*51:01 | LPECRLQSL | 0.499
HLA-B*51:01 | IAIVGIWSI | 0.204
HLA-B*08:01 | LPECRLQSL | 0.113
HLA-B*35:01 | SPTKKIADY | 0.183
HLA-B*35:01 | YINNYNYLY | 0.292

### Optimized vaccine after the greedy search ###
Polytope vaccine with 6 neo-epitopes: RLQSLQTYVlmFIAGLIAIVkLTDEMIAQYwrqmKIADYNYKLslVLNDILSRLkNYNYLYRLFydiYLQPRTFLLinaifQYIKWPWYIKCYGVSPTKgSIIAYTMSL
Table1. Presented peptides in the selected-epitopes
Alleles  |  Epi  |  %Rank
HLA-A*02:01 | RLQSLQTYV | 0.062
HLA-A*02:01 | FIAGLIAIV | 0.241
HLA-A*02:01 | KIADYNYKL | 0.067
HLA-A*02:01 | VLNDILSRL | 0.028
HLA-A*02:01 | YLQPRTFLL | 0.013
HLA-A*02:01 | SIIAYTMSL | 0.300
HLA-A*01:01 | LTDEMIAQY | 0.001
HLA-A*03:01 | KCYGVSPTK | 0.253
HLA-A*24:02 | NYNYLYRLF | 0.054
HLA-A*24:02 | QYIKWPWYI | 0.019
HLA-B*08:01 | YLQPRTFLL | 0.019
HLA-B*08:01 | SIIAYTMSL | 0.448
HLA-B*35:01 | LTDEMIAQY | 0.342

Table2. Presentation of neo-epitopes
Alleles  |    |  Epi  |  %Rank
HLA-A*03:01 | RLKNYNYLY | 0.469
HLA-A*24:02 | IYLQPRTFL | 0.077
HLA-A*24:02 | TFLLINAIF | 0.446
HLA-A*24:02 | IFQYIKWPW | 0.467
HLA-B*08:01 | DIYLQPRTF | 0.377
HLA-B*44:02 | TDEMIAQYW | 0.361

Running time is: 718s
### Optimized vaccine after the monte carlo ###
Polytope vaccine with 1 neo-epitopes: YLQPRTFLLdawRLQSLQTYVgwrlwKIADYNYKLnknlSIIAYTMSLdrsLTDEMIAQYrkidsQYIKWPWYItiiNYNYLYRLFyaFIAGLIAIVragKCYGVSPTKrsdtewVLNDILSRL
Table1. Presented peptides in the selected-epitopes
Alleles  |  Epi  |  %Rank
HLA-A*02:01 | YLQPRTFLL | 0.013
HLA-A*02:01 | RLQSLQTYV | 0.062
HLA-A*02:01 | KIADYNYKL | 0.067
HLA-A*02:01 | SIIAYTMSL | 0.300
HLA-A*02:01 | FIAGLIAIV | 0.241
HLA-A*02:01 | VLNDILSRL | 0.028
HLA-A*01:01 | LTDEMIAQY | 0.001
HLA-A*03:01 | KCYGVSPTK | 0.253
HLA-A*24:02 | QYIKWPWYI | 0.019
HLA-A*24:02 | NYNYLYRLF | 0.054
HLA-B*08:01 | YLQPRTFLL | 0.019
HLA-B*08:01 | SIIAYTMSL | 0.448
HLA-B*35:01 | LTDEMIAQY | 0.342

Table2. Presentation of neo-epitopes
Alleles  |    |  Epi  |  %Rank
HLA-A*24:02 | KWPWYITII | 0.388

Running time is: 6898s
